Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies-Reference-Cited by-同舟云学术

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

Published:2018-03-07 Issue:4 Volume:35 Page:563-576
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Louis Edouard J.,Reinisch Walter,Schwartz David A.,Löfberg Robert,Robinson Anne M.,Berg Sofie,Wang Anthony W.,Maa Jen-fue,Huang Bidan,Pappalardo Brandee

Funder

AbbVie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-018-0678-0.pdf

Reference40 articles.

1. Zippi M, Corrado C, Pica R, et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol. 2014;20:17463–7.

2. Vavricka SR, Brun L, Ballabeni P, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110–9.

3. Ott C, Takses A, Obermeier F, Schnoy E, Muller M. Smoking increases the risk of extraintestinal manifestations in Crohn’s disease. World J Gastroenterol. 2014;20:12269–76.

4. Isene R, Bernklev T, Hoie O, et al. Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol. 2015;50:300–5.

5. Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239–54.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management;Digestive Diseases and Sciences;2024-01-13

2. Choosing the Right Therapy at the Right Time for Pediatric Inflammatory Bowel Disease;Gastroenterology Clinics of North America;2023-09

3. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2023-06-23

4. Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?;Biomedicines;2022-03-23

5. Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom?;Current Research in Pharmacology and Drug Discovery;2022